Novo Nordisk Faces Class Claims Over GLP-1 Patent Tactics
By Elliot Weld · January 26, 2026, 4:45 PM EST
A South Carolina drug company has launched a proposed class action against major pharmaceutical company Novo Nordisk, alleging it engaged in anticompetitive behavior to prolong its monopoly against generic competition for...
To view the full article, register now.